Maximize Your Impact at NextGen Biomed 2026
NextGen Biomed 2026, taking place on March 24 at the Queen Elizabeth II Centre in London, is a critical touchpoint for global healthcare innovators, biotech manufacturers, diagnostics leaders, and medtech executives. The event serves as a high-value meeting ground for strategic discussions around R&D investment, regulation, clinical innovation, and commercialization pathways.
Attendees include C-suite leaders, clinical development heads, regulatory strategists, procurement directors, and digital health decision-makers from across Europe, North America, and Asia. Many arrive with live initiatives in motion—whether building supplier partnerships, evaluating new technologies, or shaping budget allocations for 2026 and beyond.
With decision-makers from both established pharma as well as early-stage biotech present, sales and marketing teams have direct access to organizations actively looking to scale research, validate new platforms, and accelerate go-to-market timelines. Using Vendelux’s enriched attendee list allows teams to prioritize outreach to top targets, understand strategic focus areas, and walk into meetings aligned to real needs—not just generic capabilities.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Biopharma executives don’t waste time on vague value propositions or exploratory calls. They expect precision and industry fluency. Vendelux’s enriched conference attendee list gives go-to-market teams the ability to segment by company type—whether large pharma, CRO, diagnostics firm, or venture-backed biotech—and engage with tailored messaging around clinical trial support, manufacturing scale-up, or market access.
Sales teams can identify procurement and partnership leads to secure meetings in advance of the event, positioning their solution around the attendee’s therapeutic area or commercial model. Marketing can sync campaigns with segment-specific talking points, from precision diagnostics to AI-powered platforms. Revenue operations teams can route high-value prospects to the right reps and plan coverage based on who is attending and what they influence.
After the event, follow-up campaigns can reference booth conversations, panels attended, or investment priorities signaled through in-session comments—turning post-show outreach into meaningful relationship momentum. Leveraging enriched attendee data helps teams understand how to get more meetings, close partnership gaps on-site, and keep the right discussions warm long after London.
Timing Is Everything
NextGen Biomed 2026 will be held on March 24, 2026. With just under a year to go, teams that begin outreach in Q3 and Q4 of 2025 will have a clear advantage. Medical and life sciences buyers operate on well-defined budget cycles and typically finalize partner conversations several months before public events.
Using Vendelux to uncover key attendees lets you lock in time with clinical and commercial executives before their calendars are full. Aligning email and outbound campaigns with attendee interests—while referencing shared event goals—is a proven way to land purposeful conversations. The earlier you activate outreach around this attendee list, the greater the chance of converting interest into scheduled demos or contract discussions during the event itself.
What’s Included in the NextGen Biomed 2026 Attendee List?
Vendelux provides visibility into executives expected to attend NextGen Biomed 2026 through organizer-sourced registration data combined with predictive modeling. Clients can upload a list of target accounts to match and prioritize outreach.
The enriched data includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email addresses, and available phone numbers. This comprehensive dataset supports pre-event targeting, in-event coordination, and post-event follow-up optimization.
Where Is NextGen Biomed 2026?
The event will be held at the Queen Elizabeth II Centre in London, England, United Kingdom.
When Is NextGen Biomed 2026?
NextGen Biomed 2026 is scheduled for March 24, 2026.
What Type of Event Is NextGen Biomed 2026?
NextGen Biomed 2026 is a leading global conference for medical technology, biotech, diagnostics, and digital health innovation. The event features keynote presentations from industry leaders, expert panels on policy and commercialization, startup showcases, and partnership matchmaking opportunities for emerging science, capital investment, and global scale-up.
How Many People Attend NextGen Biomed 2026?
NextGen Biomed 2026 is expected to host approximately 1,000 attendees from over 30 countries. Audiences consist largely of VP-level and above leaders in biotech development, medtech commercialization, digital health innovation, venture capital, and enterprise healthcare strategy.
